Case Report: Drug-Induced Rhabdomyolysis after Concomitant Use of Clarithromycin, Atorvastatin, and Lopinavir/Ritonavir in a Patient with HIV
- 1 May 2003
- journal article
- case report
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 17 (5), 207-210
- https://doi.org/10.1089/108729103321655854
Abstract
A case report of drug-induced rhabdomyolysis in a 34-year-old HIV-infected male with a history of liver disease and concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir is presented.Keywords
This publication has 19 references indexed in Scilit:
- ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of StatinsCirculation, 2002
- Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047AIDS, 2002
- FDA Adverse Event Reports on Statin-Associated RhabdomyolysisAnnals of Pharmacotherapy, 2002
- Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 2002
- Interactions among Drugs for HIV and Opportunistic InfectionsNew England Journal of Medicine, 2001
- Rhabdomyolysis Secondary to a Drug Interaction between Simvastatin and ClarithromycinAnnals of Pharmacotherapy, 2001
- Drug-Drug Interactions of Clinical Significance in the Treatment of Patients with Mycobacterium avium Complex DiseaseClinical Pharmacokinetics, 2000
- The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycinClinical Pharmacology & Therapeutics, 2000
- Pharmacokinetic interaction between ritonavir and clarithromycin*Clinical Pharmacology & Therapeutics, 1998
- Rhabdomyolysis: a review of the literatureClinical Neurology and Neurosurgery, 1993